This research evaluated the results of biocontrol Bacillus and fermenting micro organism addition on the microbial group, metabolic features and antibiotic resistance genes (ARGs) of recent prickly ash seed oil meal (PSOM)-biochar composting. The outcomes confirmed that the addition of Bacillus subtilis and fermentation micro organism considerably elevated the NH4+-N, bacterial abundance and fungal variety of compost whereas lowering the relative abundances (RAs) of carbon metabolism genes in mature compost.
NH4+-N was considerably correlated with microbial abundance and variety, and its improve was intently associated to microbial amino acid metabolism. The addition of biocontrol and fermenting micro organism modified the RAs of ARGs, which was attributable to modifications within the potential hosts Proteobacteria, Bacteroidota and Firmicutes within the compost. Consequently, including Bacillus and fermenting micro organism into PSOM to make composting was steered as an efficient methodology to advertise nutrient transformation, regulate microbial exercise and reduce RAs of tetracycline and vancomycin ARGs.
Genetic Microbial Supply Monitoring Assist QMRA Modeling for a Riverine Wetland Consuming Water Useful resource
Riverine wetlands are necessary pure habitats and comprise useful ingesting water assets. The transport of human- and animal-associated fecal pathogens into the floor water our bodies poses potential dangers to water security. The intention of this research was to develop a brand new integrative modeling strategy supported by microbial supply monitoring (MST) markers for quantifying the transport pathways of two necessary reference pathogens, Cryptosporidium and Giardia, from exterior (allochthonous) and inner (autochthonous) fecal sources in riverine wetlands contemplating protected ingesting water manufacturing.
The probabilistic-deterministic mannequin QMRAcatch (v 1.1 python backwater) was modified and prolonged to account for short-time variations in movement and microbial transport at hourly time steps. As enter to the mannequin, we decided the discharge charges, volumes and inundated areas of the backwater channel based mostly on 2-D hydrodynamic movement simulations.
To check if we thought-about all related fecal air pollution sources and transport pathways, we validated QMRAcatch utilizing measured concentrations of human, ruminant, pig and chook related MST markers in addition to E. coli in a Danube wetland space from 2010 to 2015. For the mannequin validation, we obtained MST marker decay charges in water from the literature, adjusted them inside confidence limits, and simulated the MST marker concentrations within the backwater channel, leading to imply absolute errors of < 0.7 log10 particles/L (Kruskal-Wallis p > 0.05).
Within the eventualities, we investigated (i) the affect of river discharges into the backwater channel (allochthonous sources), (ii) the resuspension of pathogens from animal fecal deposits in inundated areas, and (iii) the pathogen launch from animal fecal deposits after rainfall (autochthonous sources). Autochthonous and allochthonous human and animal sources resulted in imply hundreds and concentrations of Cryptosporidium and Giardia (oo)cysts within the backwater channel of 3-13 × 109 particles/hour and 0.4-1.2 particles/L throughout floods and rainfall occasions, and in required pathogen therapy reductions to realize protected ingesting water of 5.0-6.2 log10. The integrative modeling strategy helps the sustainable and proactive ingesting water security administration of alluvial backwater areas.
Put up-digestate composting shifts microbial composition and degrades antimicrobial resistance genes
Put up-digestate remedies might scale back the danger linked to Antibiotic Resistant Genes (ARGs) launch with digestate direct land utility. Thus, this research aimed to judge post-digestate composting and co-composting with biogas manufacturing feedstock (maize silage, meals processing waste, and poultry litter) impact on abundance of chosen ARGs: erm(B), tet(Ok), tet(M), tet(O), and tet(S) genes. Greater than 80% of all ARGs had been eliminated after 90 days of composting however removals from co-composting had been decrease. Bacteroidetes, Firmicutes, and Proteobacteria dominated recent digestate, and a community evaluation indicated that these had been potential hosts of ARGs.
The emergence of Actinobacteria (dominant), Planctomycetes, and Verrucomicrobia phyla throughout composting shifted the microbial composition. Furthermore, canonical correspondence evaluation confirmed hint parts explaining 90% variations in ARGs abundance. The research illustrates significance of post-digestate composting in mitigating ARGs launch, and effectiveness might be linked to shift in microbial composition and hint parts launch.
A watershed impacted by anthropogenic actions: Microbial group alterations and reservoir of antimicrobial resistance genes
Water is the primary useful resource for sustaining life. Anthropic actions affect the microbial epidemiological chain in watersheds, which may act as methods of disseminating microorganisms proof against antimicrobial medication, with impacts on human, animal, and environmental well being. Right here, we characterised aquatic microbial communities and their resistomes in samples collected alongside Rio das Ostras watershed throughout two seasons. Floor water samples had been collected at eleven websites from the Jundiá, Iriry, and Rio das Ostras rivers in two seasons (dry and moist season).
Microbial DNA was extracted, high-throughput sequenced and screened for antimicrobial resistance genetic (ARG) markers. The physicochemical traits and the microbiota information confirmed that Rio das Ostras watershed may be divided into three nicely outlined parts: rural, city, and marine. Rural areas had been enriched by micro organism sometimes present in limnic environments and Patescibacteria phyla. The city portion was characterised by websites with low pH and teams related to iron oxidation. Some genera of medical relevance had been additionally recognized, although in comparatively low abundance.
The marine web site was enriched primarily by Cyanobacteria and micro organism that confirmed robust correlation with conductivity, salinity, and chloride. Twenty-six ARG markers had been recognized on the resistome, being discovered most incessantly within the city space, regardless of being current in rural websites. Amongst them had been some associated to courses of nice medical concern, corresponding to genes coding for extended-spectrum beta-lactamase (blaCTX-M and blaTEM), resistance to carbapenems (blaKPC) and to methicillin by Staphylococcus aureus (mecA).
Mouse Anti-Human MIG |
|||
| MBS690197-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-006mL | MyBiosource | 0.06mL | EUR 335 |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-012mL | MyBiosource | 0.12mL | EUR 520 |
Mouse anti Human CXCL9/MIG Monoclonal Antibody |
|||
| MBS2543500-02mL | MyBiosource | 0.2mL | EUR 800 |
Human MIG (CXCL9) |
|||
| MBS691716-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human MIG (CXCL9) |
|||
| MBS691716-002mg | MyBiosource | 0.02mg | EUR 450 |
Human MIG (CXCL9) |
|||
| MBS691716-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
MIG/CXCL9, Human |
|||
| HY-P7253 | MedChemExpress | 10ug | EUR 321.6 |
MIG, CXCL9, human |
|||
| RC312-20 | Bio Basic | 5ug | EUR 125.26 |
Human MIG Recombinant |
|||
| MBS553131-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human MIG Recombinant |
|||
| MBS553131-002mg | MyBiosource | 0.02mg | EUR 245 |
MIG, human recombinant |
|||
| 4240-1000 | Biovision | each | EUR 5475.6 |
MIG, human recombinant |
|||
| 4240-20 | Biovision | each | EUR 346.8 |
anti- MIG antibody |
|||
| FNab05188 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against MIG |
|||
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-01mg | MyBiosource | 0.1mg | EUR 375 |
Anti-Human CXCL9/MIG Antibody |
|||
| MBS1569896-5x01mg | MyBiosource | 5x0.1mg | EUR 1390 |
Human MIG ELISA Kit |
|||
| GWB-SKR051 | GenWay Biotech | 96 Tests | Ask for price |
CXCL9 / MIG (74-103) (Human) |
|||
| 045-62 | PHOENIX PEPTIDE | 100 μg | EUR 289.44 |
CXCL9 / MIG (77-103) (Human) |
|||
| 045-63 | PHOENIX PEPTIDE | 100 μg | EUR 257.04 |
MIG (Human) ELISA Kit |
|||
| EKA51867-5x96T | Biomatik Corporation | 5x96T | Ask for price |
MIG (Human) ELISA Kit |
|||
| EKA51867-96T | Biomatik Corporation | 96T | EUR 446.9 |
Human CXCL9 (MIG) ELISA |
|||
| GWB-CXCL9E | GenWay Biotech | 96 well | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02002 | CHI Scientific | 5µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02003 | CHI Scientific | 20µg | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| 7-02004 | CHI Scientific | 1mg | Ask for price |
Human MIG (CXCL9), (Recombinant) |
|||
| 22060423-1 | Bio-WORLD | 5 µg | EUR 190.94 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Human MIG (CXCL9) |
|||
| MBS142040-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Recombinant Human MIG (CXCL9) |
|||
| HECXP-0901 | Cyagen | 5ug | Ask for price |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-002mg | MyBiosource | 0.02mg | EUR 385 |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human MIG (CXCL9) |
|||
| MBS4159693-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Recombinant Human MIG/CXCL9 |
|||
| P1213-.005 | ApexBio | 5ug | EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.1 | ApexBio | 100ug | EUR 900.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG/CXCL9 |
|||
| P1213-.5 | ApexBio | 500ug | EUR 2020.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100665 | ABM | 20 µg | EUR 235 |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Recombinant Human MIG (CXCL9) |
|||
| Z100669 | ABM | 1.0 mg | EUR 3900 |
|
Description: MIG (CXCL9) protein belongs to the family of chemotactic cytokines known as chemokines. The synthesis of MIG is specifically induced in macrophages and in other cells by IFN-gamma.Human neutrophils produce mig in response to IFN-gamma in combination with either TNF-alpha or bacterial lipopolysaccharides and this response is blocked by IL-10 and IL-4. MIG is a chemoattractant for stimulated but not resting T cells, however it is not active on neutrophils or monocytes. |
|||
Anti- Monokine Induced by IFN-gamma (MIG) Human Antibody |
|||
| GWB-B1A431 | GenWay Biotech | 0.1 mg | Ask for price |
Recombinant Human CXCL9 (MIG) |
|||
| 6565 | Immunochemistry | 5 µg | EUR 194 |
CXCL9 / MIG, recombinant (Human) |
|||
| 033-15 | PHOENIX PEPTIDE | 10 μg | EUR 390.96 |
MIG/CXCL9 (Recombinant) Human |
|||
| GWB-4B8A74 | GenWay Biotech | 0.02 mg | Ask for price |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-0005mg | MyBiosource | 0.005mg | EUR 305 |
Recombinant Human CXCL9 (MIG) |
|||
| MBS258295-5x0005mg | MyBiosource | 5x0.005mg | EUR 1210 |
MIG Human Recombinant (CXCL9) |
|||
| rAP-0213 | Angio Proteomie | Inquiry | Ask for price |
Human CXCL9/MIG Antibody Pair Set |
|||
| ABPR-ZB074 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human CXCL9/MIG |
|||
Anti-Human MIG Rabbit Polyclonal Antibody |
|||
| TA328386 | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Monoclonal anti-human CXCL9 (MIG) |
|||
| hAP-0220 | Angio Proteomie | 100ug | EUR 250 |
Sheep Polyclonal anti-Human CXCL9 (MIG) |
|||
| hAP-5823 | Angio Proteomie | 50ug | EUR 400 |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-01mg | MyBiosource | 0.1mg | EUR 405 |
InVivoMAb Anti-Human CXCL9/MIG (Iv0087) |
|||
| MBS1570117-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Human MIG/CXCL9 ELISA Kit |
|||
| E16HE0067 | EnoGene | 96T | EUR 833.33 |
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.48 | EnoGene | 48T | EUR 295 |
|
Description: 8pg/ml |
|||
Human MIG/CXCL9 ELISA kit |
|||
| E22-HC114.96 | EnoGene | 96T | EUR 395 |
|
Description: 8pg/ml |
|||
Human MIG/CXCL9 ELISA KIT |
|||
| E42EH-272 | EnoGene | 96T/48T | EUR 795 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-48Tests | MyBiosource | 48Tests | EUR 390 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-5x96Tests | MyBiosource | 5x96Tests | EUR 2275 |
Human MIG/CXCL9 ELISA Kit |
|||
| MBS8579179-96Tests | MyBiosource | 96Tests | EUR 495 |
Human MIG/CXCL9 ELISA Kit |
|||
| RK04210 | Abclonal | 96T | EUR 322.37 |
Human MIG/CXCL9 ELISA Kit |
|||
| RK00126 | Abclonal | 96 Tests | EUR 322.37 |
Human MIG / CXCL9 GENLISA ELISA |
|||
| KBH0049 | Krishgen | 1 x 96 wells | EUR 286 |
Human CXCL9/MIG ELISA Kit |
|||
| E28L0571 | EnoGene | 96T | EUR 666.67 |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-5x96Tests | MyBiosource | 5x96Tests | EUR 2680 |
CXCL9 / MIG Human ELISA Kit |
|||
| MBS355396-96Tests | MyBiosource | 96Tests | EUR 590 |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-5x96Tests | MyBiosource | 5x96Tests | EUR 2200 |
Human CXCL9/MIG ELISA Kit |
|||
| MBS8123906-96Tests | MyBiosource | 96Tests | EUR 480 |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-1x96Wells | MyBiosource | 1x96Wells | EUR 520 |
MIG (Human) LumiAb ELISA Kit |
|||
| MBS9510805-5x96Wells | MyBiosource | 5x96Wells | EUR 2395 |
Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| JOT-PR1091 | Jotbody | 5µg | EUR 205 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of ＞1 x 104 IU/mg. |
|||
Recombinant Human MIG (rHuMIG/CXCL9) |
|||
| PR1091 | Bioworld Biotech | 5µg | EUR 158 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of ＞1 x 104 IU/mg. |
|||
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-1x96Wells | MyBiosource | 1x96Wells | EUR 500 |
MIG (Human) OmniKine ELISA Kit |
|||
| MBS9501877-5x96Wells | MyBiosource | 5x96Wells | EUR 2300 |
MIG (Human) Sandwich ELISA Kit |
|||
| OK-0150 | Assay Biotech | 1Kit | EUR 217 |
|
Description: MIG (Human) Colorimetric Sandwich ELISA Kit |
|||
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072 | ReliaTech | 20 µg | EUR 196.35 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Human MIG (CXCL9) Recombinant Protein |
|||
| 100-072S | ReliaTech | 5 µg | EUR 92.4 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Recombinant Human MIG/CXCL9 protein |
|||
| CD01286-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | EUR 176 |
|
Description: CXCL9 is a T-cell chemoattractant induced by IFN-γ belonging to the CXC chemokine family and it is also known as Monokine induced by gamma interferon (MIG). CXCL9 is closely related to two other CXC chemokines called CXCL10 and CXCL11 and they all elicit their chemotactic functions by interacting with the chemokine receptor CXCR3. CXCL9 is a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response and chemotactic for activated T-cells. Recombinant human CXCL9 contains 103 amino acids which is a single non-glycosylated polypeptide chain. The human CXCL9 shares 75 % and 67 % a.a. sequence identity with mouse and rat CXCL9. |
|||
Recombinant Human MIG (CXCL9) Protein |
|||
| PROTQ07325-2 | BosterBio | 20ug | EUR 380.4 |
|
Description: MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. |
|||
Purified recombinant Human MIG protein |
|||
| MBS5308825-002mg | MyBiosource | 0.02mg | EUR 435 |
Purified recombinant Human MIG protein |
|||
| MBS5308825-5x002mg | MyBiosource | 5x0.02mg | EUR 1905 |
Recombinant Human (E.Coli) MIG (CXCL9) |
|||
| RP-1035 | Alpha Diagnostics | 5 ug | EUR 196.8 |
Human MIG Recombinant Protein Lyophilized |
|||
| IHUMIGRLY5UG | Innovative research | each | EUR 341 |
|
Description: Human MIG Recombinant Protein Lyophilized |
|||
Human MIG Recombinant Protein Lyophilized |
|||
| MBS8432766-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535 | Creative Diagnostics | 1 mg; 5 mg | Ask for price |
|
Description: Armenian Hamster |
|||
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Armenian Hamster Anti-Mouse CXCL9 (MIG) Monoclonal antibody, clone MIG-2F5.5 |
|||
| CABT-L4535-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-0005mg | MyBiosource | 0.005mg | EUR 160 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-005mg | MyBiosource | 0.05mg | EUR 290 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-1mg | MyBiosource | 1mg | EUR 2200 |
MIG/CXCL9 Protein, Human, Recombinant |
|||
| MBS8120554-5x1mg | MyBiosource | 5x1mg | EUR 9755 |
Human CXCL9/MIG Recombinant Protein |
|||
| PROTQ07325 | BosterBio | Regular: 20ug | EUR 250 |
|
Description: Human CXCL9/MIG Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 23-125aa. Application(s): SDS-PAGE. |
|||
MIG Human Recombinant Protein (CXCL9) |
|||
| PROTQ07325-1 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: MIG (monokine induced by gamma-interferon ) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 103 amino acids and having a molecular mass of 11700 Dalton. The MIG is purified by proprietary chromatographic techniques. |
|||
Anti-swine CXCL9 (MIG) PAb |
|||
| GWB-KI0055 | GenWay Biotech | 1 kit | Ask for price |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-1mg | MyBiosource | 1mg | EUR 3815 |
Recombinant Human MIG (CXCL9) His Tag |
|||
| MBS146507-5x1mg | MyBiosource | 5x1mg | EUR 16840 |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-01mg | MyBiosource | 0.1mg | EUR 320 |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| MBS460433-5x01mg | MyBiosource | 5x0.1mg | EUR 1390 |
Rabbit anti MIG-7 Polyclonal Antibody |
|||
| TA354753 | Origene Technologies GmbH | 100 µg | Ask for price |
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 275 |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
Recombinant Human MIG protein (C-6His) |
|||
| CD01287-50ug | Jiaxing Korain Biotech Ltd (BT Labs) | 50ug | EUR 823 |
|
Description: Recombinant Human C-X-C Motif Chemokine 9 is produced by our Mammalian expression system and the target gene encoding Thr23-Thr125 is expressed with a 6His tag at the C-terminus. |
|||
OKRC00714-96W - MIG ELISA Kit (Human) |
|||
| OKRC00714-96W | Aviva Systems Biology | 96Wells | EUR 525 |
OKAG00051-96W - MIG ELISA Kit (Human) |
|||
| OKAG00051-96W | Aviva Systems Biology | 1plate:12x8-WellMicrostrips | EUR 500 |
MIG Human Recombinant (CXCL9), His Tag |
|||
| rAP-0212 | Angio Proteomie | Inquiry | Ask for price |
CXCL9 / MIG, recombinant (Human) - ELISA Kit |
|||
| EK-033-15 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
MIG antibody |
|||
| 70R-MR007 | Fitzgerald | 50 ug | EUR 400 |
|
Description: Affinity purified Rabbit polyclonal MIG antibody |
|||
MIG antibody |
|||
| 10R-M169A | Fitzgerald | 500 ug | EUR 240 |
|
Description: Mouse monoclonal MIG antibody |
|||
MIG Antibody |
|||
| C30114-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG Antibody |
|||
| C30114-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: MIG Rabbit Polyclonal Antibody |
|||
MIG antibody |
|||
| MBS532154-05mg | MyBiosource | 0.5mg | EUR 370 |
MIG antibody |
|||
| MBS532154-5x05mg | MyBiosource | 5x0.5mg | EUR 1525 |
MIG antibody |
|||
| MBS534409-005mg | MyBiosource | 0.05mg | EUR 465 |
MIG antibody |
|||
| MBS534409-01mg | MyBiosource | 0.1mg | EUR 575 |
MIG antibody |
|||
| MBS534409-5x01mg | MyBiosource | 5x0.1mg | EUR 2430 |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-15Plates | MyBiosource | 15Plates | EUR 600 |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5Plates | MyBiosource | 5Plates | EUR 345 |
MIG/CXCL9 Matched ELISA Antibody Pair Set, Human |
|||
| MBS8118318-5x15Plates | MyBiosource | 5x15Plates | EUR 2755 |
mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
mig-21 Antibody |
|||
| CSB-PA242793XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-21 protein |
|||
mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
mig-14 Antibody |
|||
| CSB-PA296000XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-14 protein |
|||
mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
mig-18 Antibody |
|||
| CSB-PA210991XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-18 protein |
|||
mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
mig-22 Antibody |
|||
| CSB-PA005373XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-22 protein |
|||
mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
mig-13 Antibody |
|||
| CSB-PA794243XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-13 protein |
|||
mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
mig-17 Antibody |
|||
| CSB-PA631334XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-17 protein |
|||
mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
mig-23 Antibody |
|||
| CSB-PA637437XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-23 protein |
|||
mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
mig-15 Antibody |
|||
| CSB-PA637566XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-15 protein |
|||
mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
mig-39 Antibody |
|||
| CSB-PA341530XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-39 protein |
|||
mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
mig-10 Antibody |
|||
| CSB-PA327322XA01CXY-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-10 protein |
|||
mig-38 Antibody |
|||
| CSB-PA898913XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans mig-38 protein |
|||
These outcomes broaden our understanding of the microbial group of a watershed impacted by anthropogenic actions. The big variety of ARGs detected alongside the Rio das Ostras watershed contrasts with the small variety of microorganisms of medical relevance noticed, suggesting that antimicrobial resistance has arisen from non-clinical environments and microbes. Our outcomes corroborate that freshwater acts as a reservoir of antimicrobial resistance genes.